For Early-Stage MedTech Founders: What Should You Focus on Next?

 

One of the most common questions early-stage medical device founders face is:

“What should we focus on next?”

It is a reasonable question. Medical device development has many moving parts, and each one can feel urgent.

Should the team focus on:

  • Building the next prototype?

  • Refining the clinical use case?

  • Defining the regulatory pathway?

  • Planning animal or cadaver studies?

  • Preparing for first-in-human work?

  • Engaging a contract manufacturer?

  • Evaluating automation needs?

  • Raising the next round of funding?

The challenge is not simply identifying all of the work that needs to happen. The challenge is understanding the right sequence.

In MedTech, the order of decisions matters. A promising technology can lose momentum when the development path is unclear, the team begins workstreams too late, or major decisions are made without considering their impact on regulatory, clinical, manufacturing, or commercialization goals.

Medical Device Development Is Not a Straight Line

Early-stage teams often begin with a strong technical idea, an initial prototype, and enthusiasm from clinicians, investors, or advisors.

That is an important starting point. But turning that early traction into a market-ready product requires a structured development path.

A prototype may prove that a concept can work. It does not automatically establish that the device is safe, manufacturable, clinically usable, regulatory-ready, or commercially viable.

The next phase of development often requires a broader set of questions:

  • What clinical problem is the device solving?

  • Who are the intended users?

  • What does the clinical workflow look like?

  • What user needs and product requirements must be defined?

  • What regulatory pathway is most likely?

  • What testing, studies, and evidence may be needed?

  • How will the product be manufactured at scale?

  • What suppliers, processes, equipment, and quality systems will be required?

  • What milestones must be completed before the next investment, clinical, or commercialization step?

Without a roadmap, teams can make progress in one area while creating avoidable risk in another.

Why Early Road mapping Matters

The most successful medical device companies do not try to solve every challenge at once.

Instead, they create a development roadmap that identifies what must happen, when it should happen, who owns each workstream, and how the work connects to the company’s long-term commercialization strategy.

A strong roadmap helps founders make better decisions about where to invest time and capital.

It also helps prevent common issues such as:

  • Developing prototypes without clear user needs or product requirements

  • Delaying regulatory strategy until late in development

  • Planning studies before the device and clinical questions are sufficiently defined

  • Discovering manufacturing limitations after key design decisions are already locked in

  • Underestimating supplier timelines, tooling needs, or production risks

  • Moving into verification or validation with incomplete traceability and risk documentation

  • Losing time because engineering, quality, regulatory, clinical, and manufacturing teams are working toward different assumptions

A roadmap does not remove uncertainty. It creates a disciplined way to manage it.

The Four Areas Early-Stage Founders Should Think About

While every medical device program is different, there are four areas that should begin taking shape early.

1. Product Development Strategy

The product-development strategy defines how the concept will mature into a device that meets user, clinical, technical, and business needs.

This includes:

  • Understanding the unmet need and intended use

  • Defining the target user and clinical workflow

  • Developing user needs and product requirements

  • Building and iterating prototypes

  • Identifying design risks and performance expectations

  • Establishing the development plan and key design milestones

The goal is not to over-document an early concept. The goal is to build enough structure that the team can make informed design decisions as the product evolves.

2. Regulatory Strategy

Regulatory strategy should not be treated as a final checklist before submission.

It should help guide product development from the beginning.

Early regulatory planning may include:

  • Understanding likely device classification

  • Evaluating potential FDA pathways

  • Identifying possible predicate devices

  • Defining intended use and indications for use

  • Mapping likely testing and evidence requirements

  • Planning for design controls, risk management, verification, validation, and submission readiness

The earlier the regulatory strategy is considered, the easier it is to align technical development with the evidence needed to support commercialization.

3. Clinical and Feasibility Planning

Clinical insight is essential to developing a product that works in the real world.

Early feasibility, cadaver, bench, animal, formative, and other evaluation activities can provide valuable learning about:

  • Clinical workflow

  • Device usability

  • Procedure time

  • Physician and nurse interaction

  • Product performance

  • Use-related risks

  • Design improvements

  • Training needs

  • Clinical evidence strategy

The goal of early studies is not necessarily to prove that the final product is complete. It is to learn quickly and use those insights to improve the product, requirements, risk controls, and development strategy.

4. Manufacturing and Commercialization Planning

Many early-stage teams wait too long to consider how the device will be manufactured, inspected, packaged, transferred, and scaled.

Manufacturing strategy should begin during design—not after the design is considered complete.

Early considerations include:

  • Design for manufacturability

  • Component and material sourcing

  • Contract manufacturer selection

  • Assembly methods and process capability

  • Inspection and quality strategy

  • Packaging and sterilization needs

  • Production capacity and cost targets

  • Automation opportunities

  • Manufacturing transfer planning

Thinking about production early gives the team more options to reduce cost, avoid redesigns, and build a scalable path to launch.

What a Strong Development Roadmap Looks Like

A practical medical device roadmap does not need to be overly complicated. It should provide clarity around the major workstreams and decisions that will drive the program forward.

A strong roadmap typically includes:

  • Product vision, intended use, and target market

  • User needs and initial product requirements

  • Technical development and prototype milestones

  • Regulatory pathway and submission strategy

  • Clinical, feasibility, and usability study planning

  • Risk-management and design-control activities

  • Verification and validation planning

  • Supplier and contract-manufacturer strategy

  • Manufacturing readiness and transfer milestones

  • Budget, timeline, and resource requirements

  • Decision points for leadership, investors, and project stakeholders

Most importantly, the roadmap should be flexible enough to incorporate learning.

Medical device development is iterative. The purpose of a roadmap is not to pretend that nothing will change. It is to ensure the team knows how to respond when it does.

The Companies That Move Faster Build Structure Early

The medical device companies that move efficiently toward commercialization are not always the ones with the largest teams or the most funding.

They are often the ones that establish clarity early.

They understand the development path. They define milestones before they become emergencies. They consider regulatory and manufacturing implications while product decisions are still flexible. They use clinical feedback to improve the product. They bring the right stakeholders into the process before gaps become expensive.

That creates momentum.

At Birch Design, we help medical device innovators develop practical roadmaps that connect product development, regulatory strategy, clinical planning, manufacturing readiness, automation, and commercialization.

For founders who are unsure what should happen next, the answer is rarely one isolated activity.

It is usually a clear, coordinated plan for moving the right work forward in the right order.

Building a medical device and looking for clarity on your next steps? Birch Design helps teams move from concept to commercialization with stronger planning, execution, and cross-functional alignment.

 
Next
Next

The #1 Mistake MedTech Startups Make: Waiting Too Long to Plan for Manufacturing